CBD dose-dependently normalized anxiety, somatic withdrawal signs, and gene expression changes in the nucleus accumbens during acute alcohol withdrawal in mice.
Read this if you are interested in CBD as a treatment for alcohol withdrawal or alcohol use disorder.
Dose-dependentCBD at 10, 20, 40 mg/kg progressively normalized alcohol withdrawal behaviors and brain gene expression
What the researchers found
Mice undergoing spontaneous alcohol withdrawal at 6 hours showed significant somatic withdrawal signs, anxiety-like behaviors, and gene expression changes across multiple brain targets (Cnr1, Cnr2, Oprm1, Pomc in nucleus accumbens; Pomc and Th in VTA). Acute CBD (10, 20, 40 mg/kg) dose-dependently normalized both behavioral symptoms and gene expression changes in the nucleus accumbens. However, CBD did not modulate gene expression changes in the ventral tegmental area. Correlations between anxiety behaviors and gene expression in the NAcc supported the mechanistic link.
Why it matters
Alcohol withdrawal is dangerous and current treatments have significant limitations. CBD could offer a non-addictive, well-tolerated alternative that addresses both the behavioral symptoms and underlying neurobiological changes of withdrawal.
The numbers in context
- Ethanol escalation: 2.5, 3, 3.5 g/kg/12h over 15 days
- Withdrawal assessed at 6, 12, 24, 72h
- CBD doses: 10, 20, 40 mg/kg IP
- CBD effective at 6h timepoint
- Gene targets: Cnr1, Cnr2, Oprm1, Pomc (NAcc); Pomc, Th (VTA)
- CBD modulated NAcc but not VTA gene expression
How the study worked
C57BL/6J male mice received escalating oral ethanol for 15 days. Spontaneous withdrawal studied at 6, 12, 24, 72 hours. Acute CBD tested at 6h withdrawal. Behavioral testing for anxiety and somatic signs. Real-time PCR for gene expression in NAcc and VTA. Pearson correlations.
Who was studied
Male C57BL/6J mice undergoing spontaneous alcohol withdrawal
What this study cannot tell us
Only male mice studied. Acute CBD treatment may not predict chronic treatment effects. IP administration differs from human oral use. Mouse alcohol withdrawal may not fully model human withdrawal.
How to read the evidence
Preclinical animal study with behavioral and molecular endpoints. Strong mechanistic evidence but requires human validation.
When this study was published
Published in 2023. Part of growing preclinical evidence for CBD in alcohol use disorder.
The bigger picture
The opioid and cannabinoid systems in the nucleus accumbens are increasingly recognized as key mediators of alcohol withdrawal. CBD's ability to normalize these changes provides a mechanistic basis for clinical trials of CBD in alcohol use disorder.
Questions still open
- Would chronic CBD treatment prevent alcohol withdrawal if started before cessation?
- Why does CBD affect NAcc but not VTA gene expression?
- Could CBD reduce the risk of alcohol withdrawal seizures?
Read the original research
Cannabidiol regulates behavioral and brain alterations induced by spontaneous alcohol withdrawal.
Neuropharmacology, 233, 109549
Citation
Gasparyan, Ani; Navarrete, Francisco; Navarro, Daniela; Manzanares, Jorge. (2023). Cannabidiol regulates behavioral and brain alterations induced by spontaneous alcohol withdrawal.. Neuropharmacology, 233, 109549. https://doi.org/10.1016/j.neuropharm.2023.109549